GlassScriptPhysician profile
William John Knaus
NPI 1336379288
$529.49
in general payments reported to CMS, 2019-2025
9 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $125 · 2023: $69.18 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $169.73 | 2019 | |
| Biocircuit Technologies INC | $106.58 | 2025 | Nerve Tape |
| Integra Lifesciences Corporation | $73.56 | 2020 | |
| Ethicon US, LLC | $62.38 | 2019-2020 | |
| Rti Surgical, INC | $39.38 | 2023 | |
| Acumed LLC | $29.80 | 2023 | Acumed, Inframe Implant |
| Axogen | $20.71 | 2020 | |
| Tei Biosciences INC | $14.74 | 2019 | |
| Depuy Synthes Sales INC. | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Knaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.